Johnson & Johnson Innovation's JLABS: " Helping big ideas from small beginnings get off the ground.”
(Fierce Biotech) During a Fierce JPM Week executive interview, Melinda Richter, Global Head of Johnson & Johnson Innovation – JLABS, discusses the big company advantage of the global incubator network offers to early-stage innovators.
Can you help I.D. Neurotoxicity in Immunotherapies?
Visionaries are invited to submit methods and technologies aiming to optimize patient care for immunotherapies within the hematologic malignancy space by enabling early detection of neurotoxic events.
What will it take to achieve our vision of a world without disease?
As we look to the future of preventing, intercepting, and curing disease, Dr. Bill Hait shares how bold thinking and first-of-its-kind collaboration can help us get there.